These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3814216)

  • 1. Isolation and structural elucidation of urinary metabolites of ciprofloxacin.
    Gau W; Kurz J; Petersen U; Ploschke HJ; Wuensche C
    Arzneimittelforschung; 1986 Oct; 36(10):1545-9. PubMed ID: 3814216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans.
    Tanimura H; Tominaga S; Rai F; Matsumoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1417-20. PubMed ID: 3790196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structure elucidation of urinary metabolites of mitoxantrone.
    Blanz J; Mewes K; Ehninger G; Proksch B; Greger B; Waidelich D; Zeller KP
    Cancer Res; 1991 Jul; 51(13):3427-33. PubMed ID: 2054783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural identification and characterization of impurities in moxifloxacin.
    Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
    J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and structure elucidation of an intermediate in the photodegradation of ciprofloxacin.
    Torniainen K; Askolin CP; Mattinen J
    J Pharm Biomed Anal; 1997 Nov; 16(3):439-45. PubMed ID: 9589402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat.
    Okushio K; Suzuki M; Matsumoto N; Nanjo F; Hara Y
    Drug Metab Dispos; 1999 Feb; 27(2):309-16. PubMed ID: 9929521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of seven glucuronide conjugates of andrographolide in human urine.
    Cui L; Qiu F; Yao X
    Drug Metab Dispos; 2005 Apr; 33(4):555-62. PubMed ID: 15644451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of preparative high performance liquid chromatography with tandem mass spectrometric directed fraction collection for the isolation and characterisation of drug metabolites in urine by nuclear magnetic resonance spectroscopy and liquid chromatography/sequential mass spectrometry.
    Plumb RS; Ayrton J; Dear GJ; Sweatman BC; Ismail IM
    Rapid Commun Mass Spectrom; 1999; 13(10):845-54. PubMed ID: 10353222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of [14C]-ciprofloxacin in experimentally induced intramuscular abscesses of rats.
    Steinke W; Haller I; Ruehl-Fehlert C
    Arzneimittelforschung; 1986 Nov; 36(11):1663-6. PubMed ID: 3814223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal liquid chromatographic separation methods in the study of ethimizol metabolism in man.
    Soltés L
    Biomed Chromatogr; 1992; 6(4):177-82. PubMed ID: 1643385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urinary metabolites of orally administered N,N-dimethyl-p-toluidine in male F344 rats.
    Kim NC; Ghanbari K; Kracko DA; Weber WM; McDonald JD; Dix KJ
    J Toxicol Environ Health A; 2007 May; 70(10):781-8. PubMed ID: 17454554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure elucidation of a photodegradation product of ciprofloxacin.
    Torniainen K; Mattinen J; Askolin CP; Tammilehto S
    J Pharm Biomed Anal; 1997 Apr; 15(7):887-94. PubMed ID: 9160254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometrically detected directly coupled high performance liquid chromatography/nuclear magnetic resonance spectroscopy/mass spectrometry for the identification of xenobiotic metabolites in maize plants.
    Bailey NJ; Stanley PD; Hadfield ST; Lindon JC; Nicholson JK
    Rapid Commun Mass Spectrom; 2000; 14(8):679-84. PubMed ID: 10786907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The biotransformation of fenetylline].
    Rücker G; Neugebauer M; Heiden PG
    Arzneimittelforschung; 1988 Apr; 38(4):497-501. PubMed ID: 3401264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, structural elucidation and characterization of impurities in Cefdinir.
    Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.